Overview

Sirolimus Conversions in African-American Renal Transplant Recipients

Status:
Completed

Trial end date:
2014-07-01

Target enrollment:

Participant gender:

Summary

This study's focus is to compare the level effectiveness and safety of regimens involving Sirolimus, Cellcept and steroid to Prograf, Sirolimus and steroid in African-American recipients of kidney transplants.

Phase:

N/A

Details

Lead Sponsor:

Medical University of South Carolina

Collaborator:

Wyeth is now a wholly owned subsidiary of Pfizer

Treatments:

Everolimus
Mycophenolate mofetil
Mycophenolic Acid
Sirolimus
Tacrolimus